Literature DB >> 14998493

Loss of CBP causes T cell lymphomagenesis in synergy with p27Kip1 insufficiency.

Ningling Kang-Decker1, Caili Tong, Fayçal Boussouar, Darren J Baker, Wu Xu, Alexey A Leontovich, William R Taylor, Paul K Brindle, Jan M A van Deursen.   

Abstract

CBP can function as a tumor suppressor, but the mechanisms that govern oncogenesis in its absence are unknown. Here we show that CBP inactivation in mouse thymocytes leads to lymphoma. Although CBP has been implicated in the transactivation functions of p53, development of these tumors does not seem to involve loss of p53 activity. CBP-null tumors show reduced levels of p27Kip1 and increased levels of cyclin E and Skp2, two oncoproteins that can promote p27Kip1 proteolysis. Reduction of p27Kip1 by introduction of a p27Kip1-null allele into CBP knockout mice accelerates lymphomagenesis and seems to obviate the requirement for Skp2 and cyclin E upregulation. These data suggest that CBP loss mediates lymphomagenesis in cooperation with a mechanism that reduces p27Kip1 abundance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998493     DOI: 10.1016/s1535-6108(04)00022-4

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  55 in total

Review 1.  Target gene context influences the transcriptional requirement for the KAT3 family of CBP and p300 histone acetyltransferases.

Authors:  David C Bedford; Lawryn H Kasper; Tomofusa Fukuyama; Paul K Brindle
Journal:  Epigenetics       Date:  2010-01-27       Impact factor: 4.528

2.  Inhibition of S-phase kinase-associated protein 2 (Skp2) reprograms and converts diabetogenic T cells to Foxp3+ regulatory T cells.

Authors:  Ding Wang; Hanjun Qin; Weiting Du; Yueh-Wei Shen; Wen-Hui Lee; Arthur D Riggs; Chih-Pin Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-29       Impact factor: 11.205

3.  FoxOs are lineage-restricted redundant tumor suppressors and regulate endothelial cell homeostasis.

Authors:  Ji-Hye Paik; Ramya Kollipara; Gerald Chu; Hongkai Ji; Yonghong Xiao; Zhihu Ding; Lili Miao; Zuzana Tothova; James W Horner; Daniel R Carrasco; Shan Jiang; D Gary Gilliland; Lynda Chin; Wing H Wong; Diego H Castrillon; Ronald A DePinho
Journal:  Cell       Date:  2007-01-26       Impact factor: 41.582

4.  The depot-specific and essential roles of CBP/p300 in regulating adipose plasticity.

Authors:  Maria Namwanje; Longhua Liu; Michelle Chan; Nikki Aaron; Michael J Kraakman; Li Qiang
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

5.  Germline or inducible knockout of p300 or CBP in skeletal muscle does not alter insulin sensitivity.

Authors:  Vitor F Martins; Jessica R Dent; Kristoffer Svensson; Shahriar Tahvilian; Maedha Begur; Shivani Lakkaraju; Elisa H Buckner; Samuel A LaBarge; Byron Hetrick; Carrie E McCurdy; Simon Schenk
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-03-19       Impact factor: 4.310

Review 6.  The role of histone acetylation in cocaine-induced neural plasticity and behavior.

Authors:  George A Rogge; Marcelo A Wood
Journal:  Neuropsychopharmacology       Date:  2012-08-22       Impact factor: 7.853

7.  Disrupting the CH1 domain structure in the acetyltransferases CBP and p300 results in lean mice with increased metabolic control.

Authors:  David C Bedford; Lawryn H Kasper; Ruoning Wang; Yunchao Chang; Douglas R Green; Paul K Brindle
Journal:  Cell Metab       Date:  2011-08-03       Impact factor: 27.287

8.  The CREBBP Acetyltransferase Is a Haploinsufficient Tumor Suppressor in B-cell Lymphoma.

Authors:  Jiyuan Zhang; Sofija Vlasevska; Victoria A Wells; Sarah Nataraj; Antony B Holmes; Romain Duval; Stefanie N Meyer; Tongwei Mo; Katia Basso; Paul K Brindle; Shafinaz Hussein; Riccardo Dalla-Favera; Laura Pasqualucci
Journal:  Cancer Discov       Date:  2017-01-09       Impact factor: 39.397

9.  Transcriptional co-activator p300 maintains basal hepatic gluconeogenesis.

Authors:  Ling He; Karuna Naik; Shumei Meng; Jia Cao; Aniket R Sidhaye; Anlin Ma; Sally Radovick; Fredric E Wondisford
Journal:  J Biol Chem       Date:  2012-07-19       Impact factor: 5.157

10.  TLX1/HOX11-induced hematopoietic differentiation blockade.

Authors:  I Riz; S S Akimov; S S Eaker; K K Baxter; H J Lee; L Mariño-Ramírez; D Landsman; T S Hawley; R G Hawley
Journal:  Oncogene       Date:  2007-01-08       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.